CWC
ABBV icon

Carolinas Wealth Consulting’s AbbVie ABBV Stock Holding History

Carolinas Wealth Consulting’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,907
Closed -$1.66M – 4
2025
Q1 		$1.66M Sell
7,907
-2,436
-24% -$474K 0.36% 44
2024
Q4 		$1.84M Sell
10,343
-365
-3% -$67.1K 0.36% 45
2024
Q3 		$2.11M Buy
10,708
+461
+4% +$86K 0.38% 41
2024
Q2 		$1.76M Buy
10,247
+2,189
+27% +$363K 0.34% 45
2024
Q1 		$1.47M Sell
8,058
-15,488
-66% -$2.67M 0.29% 50
2023
Q4 		$1.27M Buy
23,546
+152
+0.6% +$22.2K 0.28% 50
2023
Q3 		$1.14M Buy
23,394
+125
+0.5% +$18.4K 0.28% 50
2023
Q2 		$1.07M Sell
23,269
-650
-3% -$95.3K 0.21% 68
2023
Q1 		$1.37M Buy
23,919
+388
+2% +$59.3K 0.29% 55
2022
Q4 		$1.33M Buy
23,531
+3,196
+16% +$490K 0.3% 55
2022
Q3 		$675K Sell
20,335
-291
-1% -$41.8K 0.17% 68
2022
Q2 		$812K Buy
20,626
+15,086
+272% +$2.31M 0.2% 62
2022
Q1 		$898K Buy
5,540
+144
+3% +$20.9K 0.2% 62
2021
Q4 		$731K Buy
5,396
+577
+12% +$68.2K 0.16% 71
2021
Q3 		$520K Sell
4,819
-1,052
-18% -$120K 0.12% 83
2021
Q2 		$661K Buy
5,871
+743
+14% +$83.7K 0.15% 73
2021
Q1 		$555K Buy
5,128
+531
+12% +$56.8K 0.14% 76
2020
Q4 		$493K Buy
4,597
+838
+22% +$80.5K 0.13% 82
2020
Q3 		$329K Buy
3,759
+423
+13% +$39.8K 0.11% 84
2020
Q2 		$328K Buy
3,336
+11
+0.3% +$969 0.13% 74
2020
Q1 		$253K Buy
+3,325
New +$283K 0.14% 81

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Carolinas Wealth Consulting's ABBV Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 7,907 shares — an estimated $1.66M sold.

Carolinas Wealth Consulting first reported a position in ABBV in Q1 2020 and held it in 21 quarters. The position peaked at $2.11M in Q3 2024. 3,788 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 7,907 AbbVie shares in Q2 2025, an estimated $1.66M.
  • Carolinas Wealth Consulting first reported a position in AbbVie in Q1 2020 and held it in 21 quarters.
  • Carolinas Wealth Consulting's AbbVie position peaked at $2.11M in Q3 2024.
  • 3,788 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.